GLAXF GSK plc

NEUTRAL Impact: 3/10 6-K
Horizon immediate Filed Apr 7, 2026 Processed 2mo ago SEC 0001654954-26-003274
Notable filing: 6-K
Latest settled — T+20d ⚠ clustered
GLAXF ▲ +2.37% at T+20d
NEUTRAL call ✓ call won +2.37% · α vs SPY -7.41% · entry $26.55 → $27.18
Next anchor: T+60d in 22d
Last close $24.66 (close Jun 8) · -7.12% from $26.55 entry
Entry anchored
Apr 7, 2026
via day open
T+1d
+5.57%
call +5.57% · α +3.04%
$28.03
settled 2mo ago
T+5d
+10.13%
call +10.13% · α +4.80%
$29.24
settled 8w ago
T+20d
+2.37%
call +2.37% · α -7.41%
$27.18
settled 5w ago
T+60d
call — · α —
in 22d

Price Chart

Loading chart...

Executive Summary

GSK plc repurchased 335,000 ordinary shares on April 2, 2026, as part of its ongoing buyback program, bringing total treasury shares to 256.8 million. The transaction had a volume-weighted average price of 2,121.37 GBp per share.

Actionable Insight

This is a routine buyback transaction under GSK's existing program. The purchase represents a small fraction (0.008%) of total outstanding shares and is consistent with the company's capital return strategy. No change in strategy is indicated.

Key Facts

  • GSK repurchased 335,000 ordinary shares on April 2, 2026
  • Volume-weighted average price was 2,121.37 GBp per share
  • Shares were purchased through BNP Paribas SA as part of an existing buyback program
  • Following this purchase, GSK holds 256,792,615 ordinary shares in treasury
  • Total voting rights remain at 4,059,387,166 shares

Financial Impact

Repurchased 335,000 shares at approximately $7.1 million based on the average price of £21.21 per share

treasury sharesoutstanding sharesbuyback program

Risk Factors

  • None identified - this is a standard buyback transaction

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001654954-26-003274
Document: 0001654954-26-003274-index-headers.html0001654954-26-003274
Document: 0001654954-26-003274-index.html0001654954-26-003274
Document: 0001654954-26-003274.txt0001654954-26-003274
50 reports for GLAXF
Performance horizon
42% Hit rate 5 of 12 directional calls best @ T+5▲ +7.60%Apr 1, 2026
Filters
Rows
Reports for GLAXF — sortable, filterable
Type Now
Jun 9, 2026
today
6-K
NEUTRAL ★ 1/10
awaiting T+5
Jun 9, 2026
today
6-K
BULLISH ★ 7/10
awaiting T+5
Jun 1, 2026
8d ago
6-K
NEUTRAL ★ 1/10
$24.25 $24.66▲ +1.69%▲ +4.44%$24.66 (+1.69%)
Jun 1, 2026
8d ago
6-K
NEUTRAL ★ 2/10
$24.25 $24.66▲ +1.69%▲ +4.44%$24.66 (+1.69%)
May 28, 2026
12d ago
6-K
BULLISH ★ 7/10
$24.58 $24.66▲ +0.33%▲ +0.01%$24.66 (+0.33%)
May 27, 2026
13d ago
6-K
NEUTRAL ★ 1/10
$25.57 $23.94▼ −6.37%▼ −7.58%$24.66 (−3.56%)
May 26, 2026
14d ago
6-K
NEUTRAL ★ 1/10
$25.50 $24.25▼ −4.90%▼ −5.99%$24.66 (−3.29%)
May 26, 2026
14d ago
6-K
NEUTRAL ★ 2/10
$25.50 $24.25▼ −4.90%▼ −5.99%$24.66 (−3.29%)
May 22, 2026
18d ago
6-K
NEUTRAL ★ 2/10
$26.00 $24.25▼ −6.73%▼ −8.39%$24.66 (−5.15%)
May 20, 2026
20d ago
6-K
NEUTRAL ★ 2/10
$25.70 $25.57▼ −0.51%▼ −1.74%$24.66 (−4.05%)
Showing 10 of 50

US Market Status

Market Closed — Opens in 6h 56m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access